Stay updated on Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page.

Latest updates to the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page’s footer software/version marker was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a site release rather than content changes to the clinical study information.SummaryDifference0.0%

- Check17 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check46 days agoChange DetectedRevision update added: v3.5.0. Revision v3.4.3 was removed.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision: v3.4.3 was added and v3.4.2 was removed.SummaryDifference0.0%

- Check82 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1; changes are limited to site version metadata and the removal of a non-critical government-funding maintenance notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check89 days agoChange DetectedA site-wide notice regarding government funding was added. The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

Stay in the know with updates to Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page.